Tests ear-based nerve stimulation in people with chronic kidney disease
Tests ear nerve stimulation in adults with chronic kidney disease.
Plain-language title generated from the registry record
Registry title: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) in Chronic Kidney Disease (CKD)
Key facts
- Where
- New York, United StatesSee the site
Where in United States
- NYU Langone HealthNew York, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- NYU Langone Health
- Trial code
- NCT06927024
- Record updated
- 29 October 2026
- Original description
30 patients will participate in a prospective randomized clinical trial to test the safety, tolerability and efficacy of transcutaneous auricular vagus nerve stimulation (taVNS) for autonomic nervous system (ANS) dysfunction in the chronic kidney disease (CKD) stage 3-5 setting.Read full original descriptionShow less
A Randomized, Sham-controlled Pilot Trial of a Novel Therapeutic Strategy (taVNS) for Autonomic Nervous System (ANS) Dysfunction in Chronic Kidney Disease (CKD)
30 patients will participate in a prospective randomized clinical trial to test the safety, tolerability and efficacy of transcutaneous auricular vagus nerve stimulation (taVNS) for autonomic nervous system (ANS) dysfunction in the chronic kidney disease (CKD) stage 3-5 setting.
Inclusion: Individuals age ≥18 years; Diagnosis of Chronic Kidney Disease (CKD) stage 3-5 [estimated glomerular filtration rate \≤60 mL/min/1.73m2]; Receiving care at NYU Nephrology outpatient practice; Able to provide informed consent.
Exclusion: Primary ANS disorders (e.g., Parkinson's disease); Arrhythmias; Epilepsy; Implantable cardioverter-defibrillator (ICD) or pacemaker (PPM) precluding assessment of HRV (e.g., chronic atrial fibrillation); On maintenance dialysis (HD); Symptomatic bradycardia; Presence of an implantable defibrillators; Presence of a permanent pacemaker; Unable to consent; Incarcerated individuals; Pregnant individuals.